Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma. [electronic resource]
Producer: 20060814Description: 293-7 p. digitalISSN:- 1552-6259
- Adenocarcinoma -- drug therapy
- Aged
- Anastomosis, Surgical
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Transfusion -- statistics & numerical data
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Epoetin Alfa
- Erythropoietin -- therapeutic use
- Esophageal Neoplasms -- drug therapy
- Esophagectomy
- Esophagogastric Junction
- Female
- Fluorouracil -- administration & dosage
- Gastrectomy
- Hemoglobins -- analysis
- Humans
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Neoadjuvant Therapy
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Paclitaxel -- administration & dosage
- Postoperative Complications -- epidemiology
- Prospective Studies
- Recombinant Proteins
- Stomach Neoplasms -- drug therapy
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.